Figure 1.

Significant study outcomes stratified by UCB unit–recipient ABO-compatibility status. Kaplan-Meier and cumulative incidence curves for significant study outcomes stratified by unit–recipient ABO mismatch groups. Top (left to right): Overall survival, graft failure, and grades III to IV aGVHD. Bottom (left to right): Time to absolute neutrophil count (ANC) recovery, time to platelet transfusion independence, and cumulative proportion of cGVHD.